Manhattan Associates earnings beat by $0.18, revenue topped estimates

Manhattan Associates (NASDAQ: MANH) reported robust second-quarter results, significantly exceeding analyst estimates with EPS of $1.31 against an estimated $1.13 and revenue of $272.4 million, surpassing the $263.64 million consensus. The company further bolstered its outlook by raising FY2025 EPS guidance to $4.76-$4.84 and revenue guidance to $1.07B-$1.08B, both above prior consensus. This strong beat and optimistic forward guidance prompted a significant market reaction, with the article reporting a daily gain exceeding 57%, underscoring the company's 'great performance' financial health and potential for continued positive momentum.

Analysis

Manhattan Associates (MANH) reported a robust second quarter, significantly outperforming market expectations with an EPS of $1.31, which was $0.18 above the analyst consensus of $1.13. Quarterly revenue also exceeded forecasts, coming in at $272.4 million versus the estimated $263.64 million. The company reinforced this positive operational performance by raising its full-year 2025 guidance for both earnings and revenue; the new EPS forecast of $4.76-$4.84 and revenue outlook of $1.07B-$1.08B both stand above prior consensus. This strong beat-and-raise scenario is particularly notable given the backdrop of recent analyst sentiment, which saw seven negative EPS revisions and zero positive revisions in the preceding 90 days, suggesting the strength of the results was not anticipated. While the stock has gained 16.57% in the last three months, it remains down 9.96% over the last twelve months, indicating the recent rally follows a period of underperformance. The company's fundamental health is rated as "great performance" by InvestingPro, supporting the positive results.

Key Decisions for Investors

• Given the significant earnings beat and upwardly revised full-year guidance, investors should reassess their position, as this may signal a fundamental inflection point for the company.
• Investors should monitor for impending analyst upgrades, as the strong results directly contradict the recent trend of negative EPS revisions and could act as a catalyst for further share price appreciation.
• While the outlook is strong, it is prudent to consider the stock's 16.57% gain over the last three months and evaluate if the positive news is already incorporated into the current valuation.